Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07471971

Assessment of Hypertensive Retinopathy Using Neural Network "RetinAIcheck"

Conditions: Hypertensive Retinopathy

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Enrollment: 755
Sponsor: I.M. Sechenov First Moscow State Medical University

Location: University Clinical Hospital №1, Sechenov University Moscow

Summary

The current study is aimed at estimating the diagnostic effectiveness of a developed neural network "RetinAIcheck" in grading the severity of hypertensive retinopathy in patients of the Russian population. The training data set was obtained from an open source and relabeled by seven independent retina specialists, the sample size was 30,000 fundus photographs. The test sample included 755 patients (1374 eyes). Among the 1.374 eyes, 94 were without HR (class 0), 330 had class 1, 660 had class 2, 280 had class 3, and 10 had class 4 HR.The reference standard was the result of independent grading of HR stage by two ophthalmologists, controversial clinical cases were evaluated with the involvement of a third ophthalmologist.

Eligibility Criteria

Inclusion Criteria: \- Patients with and without a diagnosis of arterial hypertension, based on medical records Exclusion Criteria: * anophthalmia, * optic nerve atrophy, * eyeball injuries, * age-related macular degeneration, * central serous chorioretinopathy, * central serous chorioretinitis, * clouding of the optical media of the eye, which affects the quality of the image.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07471971). StuddyBuddy aggregates publicly available trial information.